Status:
COMPLETED
Cryopreservation Medium With Apigenin on Post-thaw Human Sperm
Lead Sponsor:
Chulalongkorn University
Conditions:
Healthy
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the effect of apigenin supplementation in freezing medium with no apigenin supplementation in freezing medium on post-thaw human sperm motility. It will a...
Detailed Description
All normal semen samples from participants who give written informed consent and meet the eligibility requirements will be included in the study. Prepared semen samples were divided into 3 groups. 1....
Eligibility Criteria
Inclusion
- Healthy men aged 18-45 years who can receive semen analysis services at the Reproductive Biology Unit, Chulalongkorn Hospital, Thai Red Cross Society
- Normal semen analysis results according to the World Health Organization criteria (Volume ≥ 1.4 mL, Sperm concentration ≥ 16 million/mL, Total motility ≥ 42%, Progressive motility ≥ 30%)
- Giving consent
Exclusion
- A history of accidents, radiation to the testes, or a history of male reproductive system surgery
- Undescended testis
- Varicocele
- A history of taking certain medications that affect sperm production, such as chemotherapy, hormones
- Currently having sexually transmitted disease
Key Trial Info
Start Date :
October 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2025
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT06560216
Start Date
October 28 2024
End Date
March 3 2025
Last Update
March 18 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chulalongkorn Hospital
Bangkok, Thailand, 10330
2
Chulalongkorn University
Bangkok, Thailand, 10330